Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 6,498 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 6,498 shares of the stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $4.39, for a total transaction of $28,526.22. Following the completion of the sale, the chief executive officer directly owned 123,490 shares in the company, valued at $542,121.10. This trade represents a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Amit Gupta also recently made the following trade(s):

• On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.

Cardlytics Stock Performance

CDLX opened at $4.42 on Tuesday. The stock has a market cap of $25.71 million, a price-to-earnings ratio of -0.25 and a beta of 0.61. The stock’s 50 day moving average price is $6.26 and its 200-day moving average price is $8.70. Cardlytics, Inc. has a one year low of $4.25 and a one year high of $32.80.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, June 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, April 10th. Lake Street Capital set a $10.00 target price on shares of Cardlytics in a research note on Friday, May 8th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday, June 18th. Two equities research analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $10.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. grew its stake in Cardlytics by 15.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock worth $125,000 after purchasing an additional 14,273 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Cardlytics by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock worth $753,000 after buying an additional 20,908 shares during the period. Qube Research & Technologies Ltd purchased a new stake in shares of Cardlytics in the 3rd quarter worth $55,000. Boothbay Fund Management LLC bought a new position in shares of Cardlytics during the 3rd quarter worth $74,000. Finally, Virtu Financial LLC bought a new position in shares of Cardlytics during the 4th quarter worth $39,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.